PMA stimulates MUC5B gene expression through an Sp1-based mechanism in airway epithelial cells

Daphne Y C Wu, Reen Wu, Yin Chen, Natasha Tarasova, Mary Mann Jong Chang

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We previously showed that the MUC5B gene expression was elevated by phorbol 12-myristate 13-acetate (PMA) through an epidermal growth factor receptor-independent Ras/MEKK1/JNK and P38 signaling-based transcriptional mechanism. In the current study, we elucidated the molecular basis of this transcriptional regulation using promoter-reporter gene expression and chromatin immunoprecipitation (ChIP) assays with primary human bronchial epithelial cells that are cultured at the air-liquid interface. We have observed that PMA-induced MUC5B promoter activity is blocked by the Sp1-binding inhibitor, mithramycin A, in a dose-dependent manner. Deletion analysis with the MUC5B promoter construct demonstrated that both basal and PMA-induced promoter-reporter activities reside within the -222/-78 bp region relative to the transcriptional start site. NoShift transcriptional factor assays demonstrated that PMA stimulated Sp1 binding, but not STAT1 and c-Myc binding. Immunoprecipitation studies also verified the enhanced phosphorylation of Sp1 after PMA treatment. Site-directed mutagenesis and transfection studies demonstrated the involvement of Sp1-1 (-122/-114) and the Sp1-2 (-197/-186) cis elements in the basal and PMA-induced MUC5B promoter activity. The ChIP assay with anti-RNA polymerase II reconfirmed the PMA-induced MUC5B promoter activity by showing enhanced RNA polymerase II-DNA complex containing putative MUC5B Sp1-1, Sp1-2, or Sp1-3 sites. However, the ChIP assay using anti-Sp1 antibody demonstrated that the PMA-stimulated binding is only at Sp1-2. These results suggested an Sp1-based transcriptional mechanism with Sp1-1 as the regulator of basal MUC5B promoter activity and Sp1-2 as the regulator of PMA-induced MUC5B gene expression in the human airway epithelial cells.

Original languageEnglish (US)
Pages (from-to)589-597
Number of pages9
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume37
Issue number5
DOIs
StatePublished - Nov 2007
Externally publishedYes

Fingerprint

Gene expression
Acetates
Epithelial Cells
Gene Expression
Chromatin Immunoprecipitation
Assays
Chromatin
RNA Polymerase II
phorbol-12-myristate
Mutagenesis
Phosphorylation
Site-Directed Mutagenesis
Reporter Genes
Immunoprecipitation
Epidermal Growth Factor Receptor
Transfection
Anti-Idiotypic Antibodies
Air
Antibodies
DNA

Keywords

  • ChIP
  • MUC5B
  • Site-directed mutagenesis
  • Sp-1
  • Transcription

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

Cite this

PMA stimulates MUC5B gene expression through an Sp1-based mechanism in airway epithelial cells. / Wu, Daphne Y C; Wu, Reen; Chen, Yin; Tarasova, Natasha; Chang, Mary Mann Jong.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 37, No. 5, 11.2007, p. 589-597.

Research output: Contribution to journalArticle

Wu, Daphne Y C ; Wu, Reen ; Chen, Yin ; Tarasova, Natasha ; Chang, Mary Mann Jong. / PMA stimulates MUC5B gene expression through an Sp1-based mechanism in airway epithelial cells. In: American Journal of Respiratory Cell and Molecular Biology. 2007 ; Vol. 37, No. 5. pp. 589-597.
@article{880b75783ec242c2a529f186ff3424e5,
title = "PMA stimulates MUC5B gene expression through an Sp1-based mechanism in airway epithelial cells",
abstract = "We previously showed that the MUC5B gene expression was elevated by phorbol 12-myristate 13-acetate (PMA) through an epidermal growth factor receptor-independent Ras/MEKK1/JNK and P38 signaling-based transcriptional mechanism. In the current study, we elucidated the molecular basis of this transcriptional regulation using promoter-reporter gene expression and chromatin immunoprecipitation (ChIP) assays with primary human bronchial epithelial cells that are cultured at the air-liquid interface. We have observed that PMA-induced MUC5B promoter activity is blocked by the Sp1-binding inhibitor, mithramycin A, in a dose-dependent manner. Deletion analysis with the MUC5B promoter construct demonstrated that both basal and PMA-induced promoter-reporter activities reside within the -222/-78 bp region relative to the transcriptional start site. NoShift transcriptional factor assays demonstrated that PMA stimulated Sp1 binding, but not STAT1 and c-Myc binding. Immunoprecipitation studies also verified the enhanced phosphorylation of Sp1 after PMA treatment. Site-directed mutagenesis and transfection studies demonstrated the involvement of Sp1-1 (-122/-114) and the Sp1-2 (-197/-186) cis elements in the basal and PMA-induced MUC5B promoter activity. The ChIP assay with anti-RNA polymerase II reconfirmed the PMA-induced MUC5B promoter activity by showing enhanced RNA polymerase II-DNA complex containing putative MUC5B Sp1-1, Sp1-2, or Sp1-3 sites. However, the ChIP assay using anti-Sp1 antibody demonstrated that the PMA-stimulated binding is only at Sp1-2. These results suggested an Sp1-based transcriptional mechanism with Sp1-1 as the regulator of basal MUC5B promoter activity and Sp1-2 as the regulator of PMA-induced MUC5B gene expression in the human airway epithelial cells.",
keywords = "ChIP, MUC5B, Site-directed mutagenesis, Sp-1, Transcription",
author = "Wu, {Daphne Y C} and Reen Wu and Yin Chen and Natasha Tarasova and Chang, {Mary Mann Jong}",
year = "2007",
month = "11",
doi = "10.1165/rcmb.2007-0145OC",
language = "English (US)",
volume = "37",
pages = "589--597",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "5",

}

TY - JOUR

T1 - PMA stimulates MUC5B gene expression through an Sp1-based mechanism in airway epithelial cells

AU - Wu, Daphne Y C

AU - Wu, Reen

AU - Chen, Yin

AU - Tarasova, Natasha

AU - Chang, Mary Mann Jong

PY - 2007/11

Y1 - 2007/11

N2 - We previously showed that the MUC5B gene expression was elevated by phorbol 12-myristate 13-acetate (PMA) through an epidermal growth factor receptor-independent Ras/MEKK1/JNK and P38 signaling-based transcriptional mechanism. In the current study, we elucidated the molecular basis of this transcriptional regulation using promoter-reporter gene expression and chromatin immunoprecipitation (ChIP) assays with primary human bronchial epithelial cells that are cultured at the air-liquid interface. We have observed that PMA-induced MUC5B promoter activity is blocked by the Sp1-binding inhibitor, mithramycin A, in a dose-dependent manner. Deletion analysis with the MUC5B promoter construct demonstrated that both basal and PMA-induced promoter-reporter activities reside within the -222/-78 bp region relative to the transcriptional start site. NoShift transcriptional factor assays demonstrated that PMA stimulated Sp1 binding, but not STAT1 and c-Myc binding. Immunoprecipitation studies also verified the enhanced phosphorylation of Sp1 after PMA treatment. Site-directed mutagenesis and transfection studies demonstrated the involvement of Sp1-1 (-122/-114) and the Sp1-2 (-197/-186) cis elements in the basal and PMA-induced MUC5B promoter activity. The ChIP assay with anti-RNA polymerase II reconfirmed the PMA-induced MUC5B promoter activity by showing enhanced RNA polymerase II-DNA complex containing putative MUC5B Sp1-1, Sp1-2, or Sp1-3 sites. However, the ChIP assay using anti-Sp1 antibody demonstrated that the PMA-stimulated binding is only at Sp1-2. These results suggested an Sp1-based transcriptional mechanism with Sp1-1 as the regulator of basal MUC5B promoter activity and Sp1-2 as the regulator of PMA-induced MUC5B gene expression in the human airway epithelial cells.

AB - We previously showed that the MUC5B gene expression was elevated by phorbol 12-myristate 13-acetate (PMA) through an epidermal growth factor receptor-independent Ras/MEKK1/JNK and P38 signaling-based transcriptional mechanism. In the current study, we elucidated the molecular basis of this transcriptional regulation using promoter-reporter gene expression and chromatin immunoprecipitation (ChIP) assays with primary human bronchial epithelial cells that are cultured at the air-liquid interface. We have observed that PMA-induced MUC5B promoter activity is blocked by the Sp1-binding inhibitor, mithramycin A, in a dose-dependent manner. Deletion analysis with the MUC5B promoter construct demonstrated that both basal and PMA-induced promoter-reporter activities reside within the -222/-78 bp region relative to the transcriptional start site. NoShift transcriptional factor assays demonstrated that PMA stimulated Sp1 binding, but not STAT1 and c-Myc binding. Immunoprecipitation studies also verified the enhanced phosphorylation of Sp1 after PMA treatment. Site-directed mutagenesis and transfection studies demonstrated the involvement of Sp1-1 (-122/-114) and the Sp1-2 (-197/-186) cis elements in the basal and PMA-induced MUC5B promoter activity. The ChIP assay with anti-RNA polymerase II reconfirmed the PMA-induced MUC5B promoter activity by showing enhanced RNA polymerase II-DNA complex containing putative MUC5B Sp1-1, Sp1-2, or Sp1-3 sites. However, the ChIP assay using anti-Sp1 antibody demonstrated that the PMA-stimulated binding is only at Sp1-2. These results suggested an Sp1-based transcriptional mechanism with Sp1-1 as the regulator of basal MUC5B promoter activity and Sp1-2 as the regulator of PMA-induced MUC5B gene expression in the human airway epithelial cells.

KW - ChIP

KW - MUC5B

KW - Site-directed mutagenesis

KW - Sp-1

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=35848955439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848955439&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2007-0145OC

DO - 10.1165/rcmb.2007-0145OC

M3 - Article

C2 - 17600309

AN - SCOPUS:35848955439

VL - 37

SP - 589

EP - 597

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 5

ER -